NCT07191730 2026-03-19
ML-CardioTox
University Hospital, Caen
Recruiting
Clinical Trials
181 trialsNCT07442578 2026-03-18
PULSE
Dana-Farber Cancer Institute
Phase NA Active not recruiting
NCT06277388 2026-03-11
Evaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment.
Sun Yat-sen University
Active not recruiting
NCT04827563 2026-03-04
Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib
University of Chicago
Terminated
NCT06844669 2026-03-03
HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy
Washington University School of Medicine
Phase 2 Active not recruiting
NCT07158450 2026-02-25
NOECHO
Skribe Medical
Enrolling by invitation
NCT04026737 2026-02-09
CVE-CART
Abramson Cancer Center at Penn Medicine
Completed
NCT04361240 2026-02-09
Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Companion Study
Abramson Cancer Center at Penn Medicine
Completed
NCT06332131 2026-02-09
Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature
Abramson Cancer Center at Penn Medicine
Enrolling by invitation
NCT06443645 2026-02-04
SCARA-B
Centre Paul Strauss
Recruiting
NCT04044872 2026-02-02
Hyperpolarized Carbon 13-Based Metabolic Imaging to Detect Radiation-Induced Cardiotoxicity
University of Texas Southwestern Medical Center
Phase EARLY_PHASE1 Terminated
NCT06595147 2026-01-08
BE-FITTER
University of Alberta
Phase NA Recruiting
NCT06220032 2026-01-05
HO170DLBCL
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3 Recruiting
NCT06023576 2026-01-02
A Study of Blood Pressure Control During Cancer Treatment
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT07299812 2025-12-23
BRAVE-HEART
Fondazione IRCCS Policlinico San Matteo di Pavia
Recruiting
NCT07254221 2025-12-10
ROSUBREAST
Shiraz University of Medical Sciences
Phase 4 Not yet recruiting
NCT07267247 2025-12-05
Cancer Therapy-Related Cardiac Dysfunction Associated With EGFR-TKIs in Advanced EGFR-mutant Non-small Cell Lung Cancer
Taichung Veterans General Hospital
Completed
NCT04598646 2025-12-03
HIMALAYAS-P
University Health Network, Toronto
Phase NA Completed
NCT06183437 2025-12-03
STOP-MED
University Health Network, Toronto
Phase 4 Recruiting
NCT05023785 2025-11-26
HIMALAYAS
University Health Network, Toronto
Phase NA Recruiting
NCT05271162 2025-11-21
EMPACT
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 3 Recruiting
NCT03787966 2025-11-19
ATOPE
Universidad de Granada
Phase NA Completed
NCT02916316 2025-11-18
Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell
Fondazione Italiana Linfomi - ETS
Completed
NCT04790266 2025-11-18
CARDIOTOX
Oncology Institute of Southern Switzerland
Completed
NCT05559164 2025-11-14
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Rutgers, The State University of New Jersey
Phase 2 Recruiting
NCT05078190 2025-11-06
CCT2
Abramson Cancer Center at Penn Medicine
Active not recruiting
NCT04036032 2025-10-14
Role of Aerobic Exercise to Modulate Cardiotoxicity in Long Term Cancer Survivors Exposed to Anthracycline Therapy
Connecticut Children's Medical Center
Completed
NCT05377320 2025-10-14
PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study
Medical College of Wisconsin
Not yet recruiting
NCT03418961 2025-10-08
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
SWOG Cancer Research Network
Phase 3 Recruiting
NCT04305613 2025-10-02
CLARITY
Abramson Cancer Center at Penn Medicine
Active not recruiting
NCT06605833 2025-10-01
CARD-IO
Royal Marsden NHS Foundation Trust
Enrolling by invitation
NCT06350994 2025-09-02
Cardio CAR-T
Assistance Publique - Hôpitaux de Paris
Recruiting
NCT06155331 2025-08-19
Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients
Tanta University
Phase 2 Completed
NCT04892667 2025-08-13
DETECT
Assistance Publique - Hôpitaux de Paris
Phase NA Active not recruiting
NCT06132984 2025-08-01
Cardiac Magnetic Resonance Monitoring of Immune Checkpoint Inhibitor-related Cardiotoxicity
West China Second University Hospital
Recruiting
NCT03862131 2025-07-29
PROACT
Washington University School of Medicine
Phase 2 Terminated
NCT02772367 2025-07-16
Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients
Memorial Sloan Kettering Cancer Center
Recruiting
NCT04737265 2025-07-03
NTproBNP-Guide
Abramson Cancer Center at Penn Medicine
Phase 1/2 Completed
NCT07041827 2025-06-27
CLARITY
The Netherlands Cancer Institute
Completed
NCT05029154 2025-06-12
Exercise Preconditioning in Ovarian Cancer
University of Virginia
Phase NA Terminated
NCT05786014 2025-06-12
The Effects of Two Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic Chemotherapies
University of Virginia
Phase NA Completed
NCT06310330 2025-06-06
TRUST-ACE
Norwegian University of Science and Technology
Phase NA Recruiting
NCT06778122 2025-05-11
BREATHS
University College, London
Phase NA Recruiting
NCT03790943 2025-05-07
Cardio-Onco
University of Bern
Recruiting
NCT06897189 2025-04-18
Optimizing Radiation Dose and Utilizing Wearable Devices to Reduce Arrhythmia Risk in Patients Undergoing Thoracic Radiotherapy: A Prospective Cohort Study
Yonsei University
Not yet recruiting
NCT06930521 2025-04-16
JUSTIFY
Women's College Hospital
Phase NA Not yet recruiting
NCT05406635 2025-04-08
HER2BIC
Odense University Hospital
Phase NA Recruiting
NCT06256068 2025-04-06
Determinants of Physical Activity Level in Pediatric Oncological Patients Treated With Cardiotoxic Therapy - a Study Protocol
Medical University of Warsaw
Not yet recruiting
NCT04568161 2025-04-03
Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses
University of Sao Paulo General Hospital
Phase NA Completed
NCT03711110 2025-03-21
CARTIER
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Phase NA Recruiting